GEN-1013 was studied in an aggressive CT26 murine cancer model using both IT and IV administration.Significant tumor reduction was observed in both administration routes. Both IT and IV were ...

Our body's own defense system not only clears away bacteria and viruses, it can also fight cancer. However, not all tumor ...

Compromised antigen presentation ranks among the top mechanisms that render cancers non-immunogenic (non-responsive to immune ...

Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric ...

Scientists have discovered a new immunotherapy strategy that reduces cancer recurrence in mouse experimental models. The ...

Search for other works by this author on: ...

Department of Biomedical Engineering College of Engineering, Shantou University, Shantou 515063, China ...

Antibody-drug conjugates combined with immunotherapy have redefined the standard of care for advanced bladder cancer, ...

School of Biomedical Engineering, Shenzhen Campus of Sun Yat-Sen University, No. 66, Gongchang Road, Guangming District, Shenzhen, Guangdong 518107, China ...

We expect that the pan-cancer atlas and this toolkit will significantly accelerate discovery of actionable targets for cancer immunotherapy and reveal new insights in antigen presentation and tumor ...